Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Amantadine VS Ritalin in the Treatment of ADHD: a Double Blind Randomized Trial

NCT01099059 is registered in ClinicalTrials.gov with Tehran University of Medical Sciences as lead sponsor.

NCT NCT01099059
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01099059 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Amantadine VS Ritalin in the Treatment of ADHD: a Double Blind Randomized Trial
Lead sponsor
Tehran University of Medical Sciences
Phase
Phase 2
Overall status
Unknown status
Start date
April 30, 2010
Completion date
June 30, 2010
Enrollment
40 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

attention deficit hyperactivity disorder